GlaxoSmithKline S.A.E. (BIOC) Share Price — EGX

EGP 281.03+8.83%Indicator average: +0.07 (−1 to +1)

GlaxoSmithKline S.A.E. (BIOC) trades on the Egyptian Exchange (EGX) in the Health Care & Pharmaceuticals sector. Last updated 28 Oct 2026, 14:30 (Cairo time).

What is GlaxoSmithKline S.A.E.’s share price today? BIOC last traded at EGP 281.03 (+8.83% on the day), for a market value of EGP 23.47 billion and a dividend yield of 0.18%. Its 52-week range is EGP 55.1 to 609.

BIOC price performance

1W
+2.8%
1M
+20.8%
3M
+40.7%
6M
+307.6%
YTD
+341.5%
1Y
+290.3%
5Y
+1553.1%

Price change from EGX closing prices, adjusted for recorded splits and bonus issues; cash dividends are not included. A period that spans an unexplained price jump is not shown. Past performance does not indicate future results.

About GlaxoSmithKline S.A.E.

GlaxoSmithKline (Egypt) engages in the pharmaceutical and healthcare business. Its business operations are carried out through the production, packaging, marketing, sale, and distribution of medicines and other pharmaceutical products. The company was founded on January 14, 1981 and is headquartered in Cairo, Egypt.

Industry:
Medical Distributors
Employees:
800
ISIN:
EGS38171C012
Website:
www.gsk.com/en-gb/contact-us/worldwide/egypt/

BIOC key statistics

Last price
EGP 281.03
Previous close
EGP 258.24
Day change
8.83%
52-week range
EGP 55.1 – 609
Volume
685,218
Shares outstanding
83.51M
Free float
2.91%
Market cap
EGP 23.47B
P/E (trailing)
689.64
P/B
10.76
Dividend yield (FY 2018)
0.18%
ROE
4.69%
Book value / share
EGP 26.12
Beta (1Y)
0.6
50-day MA
EGP 317.78
200-day MA
EGP 155.97
RSI (14)
49.1

Data as of 28 Oct 2026, 14:30 (Cairo time). EGX market data; financial statements from company disclosures. Prices are delayed 15 minutes during EGX trading hours (Sun–Thu).

Key terms behind the BIOC figures

Market Capitalization
Market capitalization is the total market value of a company’s outstanding shares, calculated as the share price multiplied by the number of issued shares. It is the standard measure used to rank the size of listed companies and to weight them in indices such as the EGX 30. Market cap changes continuously as the share price moves.
Price-to-Earnings (P/E) Ratio
The price-to-earnings ratio divides a company’s share price by its earnings per share, showing how many pounds investors pay for each pound of annual profit. It is one of the most widely used valuation multiples for comparing listed companies within the same sector. A trailing P/E uses reported earnings, while a forward P/E uses forecast earnings.
Price-to-Book (P/B) Ratio
The price-to-book ratio compares a company’s share price with its book value per share, which is shareholders’ equity divided by the number of shares. A ratio of 1 means the stock trades at exactly its accounting net worth. The multiple is used widely for valuing banks and other asset-heavy businesses on the EGX.
Dividend Yield
Dividend yield is the annual cash dividend per share expressed as a percentage of the current share price. It measures the income a shareholder receives from distributions relative to the market price of the stock. Because the calculation uses the market price, the yield rises when the price falls and falls when the price rises, assuming the dividend is unchanged.

Frequently asked questions

What is GlaxoSmithKline S.A.E. (BIOC) share price today?
GlaxoSmithKline S.A.E. last traded at EGP 281.03 on the Egyptian Exchange (as of 28 Oct 2026, 14:30, Cairo time). Prices update every 15 minutes during EGX trading hours.
What is BIOC's market capitalization?
GlaxoSmithKline S.A.E. has a market capitalization of about EGP 23.47B.
Does BIOC pay dividends?
Yes — GlaxoSmithKline S.A.E. paid EGP 0.5 per share for fiscal 2018, a dividend yield of 0.18% at the last price.
What is BIOC's P/E ratio?
GlaxoSmithKline S.A.E. trades at a trailing price-to-earnings ratio of 689.64.
What sector is GlaxoSmithKline S.A.E. in?
GlaxoSmithKline S.A.E. is listed on the Egyptian Exchange (EGX) in the Health Care & Pharmaceuticals sector.
Where can I track BIOC?
This Starta Markets page shows GlaxoSmithKline S.A.E.'s EGX quote (delayed 15 minutes), key statistics, financial statements, dividends, technicals and news, in Arabic and English.